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Abstract 
Objectives: The determinants of gut microbiota composition and its effects on common childhood 
illnesses are only partly understood, especially in low-income settings. The aim of the present study 
was to investigate whether morbidity predicts gut microbiota composition in Malawian children and 
whether microbiota predicts subsequent morbidity. We tested the hypothesis that common infectious 
disease symptoms would be predictive of lower microbiota maturity and diversity. 
Methods: We used data from 631 participants in a randomized-controlled nutrition intervention 
trial, in which a small-quantity lipid based nutrient supplement was provided to pregnant and lactating 
mothers and their children at 6 to 18 months of age. Fecal samples were collected from the children at 
6, 12, 18, and 30 months of age and analyzed using 16S rRNA sequencing. Microbiota variables 
consisted of measures of microbiota diversity (Shannon Index), microbiota maturity (microbiota-for- 
age Z-score), and the relative abundances of taxa. Morbidity variables included gastrointestinal and 
respiratory symptoms and fever. 
Results: Diarrhea and respiratory symptoms from 11 to 12 months were predictive of lower 
microbiota-for-age Z-score and higher Shannon Index, respectively (p=0.035 and p=0.023). Morbidity 
preceding sample collection was predictive of the relative abundances of several bacterial taxa at all 
time points. Higher microbiota maturity and diversity at 6 months were predictive of a lower incidence 
rate of fever in the subsequent 6 months (p=0.007 and p=0.031). 
Conclusions: Our findings generally do not support the hypothesis that morbidity prevalence 
predicts a subsequent decrease in gut microbiota maturity or diversity in rural Malawian children. 
Certain morbidity symptoms may be predictive of microbiota maturity and diversity and relative 
abundances of several bacterial taxa. Further, microbiota diversity and maturity may be associated 
with the subsequent incidence of fever. 
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What is known 
• The first years of life are critical for the establishment of a healthy intestinal microbiota and
are characterized by rapid changes in microbial community composition.
• The composition of the intestinal microbiota has been associated with various acute and
chronic illnesses.
What is new 
• Diarrhea, respiratory tract infections, and fever may influence several aspects of the
microbiota composition, including bacterial taxa that change significantly during the first
years of life and contribute to the maturation of the gut microbial community.
• Microbiota diversity and maturity may be associated with the subsequent incidence of fever.
Introduction 
The first years of life are critical for the establishment of a healthy intestinal microbiota and are 
characterized by rapid changes in microbial community composition. In young children, microbial 
diversity increases with age and perturbations during this period have been associated with diseases 
later in life.(1–5) Recent studies have reported a link between healthy intestinal microbiota 
development and healthy child growth, with impaired microbiota development associated with growth 
faltering.(6–8) Infections can also affect the microbiota composition, and the microbiota can in turn 
influence an individual’s susceptibility to acute illnesses, including gastrointestinal and respiratory 
infections and malaria.(9–15) This is especially relevant in low-income settings in which infectious 
diseases are common and associated with malnutrition.(16,17) 
The main aim of  the present study was to investigate whether  the prevalence of common 
childhood infections predicts gut microbiota composition in children. We hypothesized that frequent 
morbidity would be predictive of perturbed microbiota development. To study the inverse direction of 
association between gut microbiota and morbidity, we further assessed whether the gut microbiota is 
associated with subsequent morbidity. To this end, we analyzed data from children who  were 
followed during the iLiNS-DYAD trial in Malawi. iLiNS-DYAD was a nutrition intervention trial 
conducted by the International Lipid-Based Nutrient Supplements Project study team (iLiNS-DYAD- 
M; NCT01239693),  which studied the effect of small-quantity  lipid-based nutrient supplements 
(LNS) on child growth.(18) The main results of the trial have been reported previously; in summary, 
provision of LNS to pregnant and lactating mothers and their children at 6 to 18 months of age did not 
promote child growth at 18 months of age.(18) Study participants were monitored closely between 
birth and 30 months of age and stool and other biological samples were collected at various time 
points. This enabled us to study the development of the gut microbiota as well as its associations with 
morbidity and several other potentially influential factors. 
Materials and Methods 
The iLiNS-DYAD trial was a randomized, controlled, and partly blinded clinical trial conducted 
in the Mangochi district in southern Malawi. The study enrolled 1391 pregnant women who were 
randomly assigned to receive either LNS or multiple-micronutrient tablets during pregnancy and until 
6 months after giving birth, or only iron and folic acid during pregnancy and placebo until 6 months 
postpartum. Of the enrolled women, the first 869 were allocated to a follow-up study, during which 
their children received either LNS supplementation (if the mother had received LNS) or no 
intervention (if the mother had received iron and folic acid or multiple micronutrients) between 6 and 
18 months of age. Children of these 869 women formed the study sample for the current analysis. 
Clinical data were collected at weekly home visits from birth until children reached 18 months of 
age and fecal samples were collected at 6, 12, 18, and 30 months of age. If a child had diarrhea, no 
fecal sample was collected and the visit was postponed by two weeks. Samples were frozen at -20°C 
within approximately 6 hours deep frozen at -80°C within 48 hours. Bacterial members of the fecal 
microbiota were characterized by PCR amplification of the variable V4 region of the 16S rRNA gene 
and sequencing of the resulting amplicons (Illumina MiSeq instrument; paired end 250 nt reads, 
Illumina Inc., San Diego, CA, USA). 16S rRNA sequences were clustered into operational taxonomic 
units (OTUs) with at least 97% sequence identity, and OTUs were assigned taxonomy based on the 
Ribosomal Database Project version 2.4 using a cutoff of 80% for the bootstrap confidence 
estimate.(19) To exclude artifacts, OTUs were filtered using a threshold of 0.1% of sequencing reads 
in at least two samples. The V4-16S sequence data generated and analyzed for this study are available 
through the European Nucleotide Archive under the study accession number PRJEB29433. 
To measure microbiota maturity, we employed a previously described Random Forests-(RF)- 
derived model that was generated from a reference cohort of healthy Malawian infants and children. 
The model was further validated among the study participants of the iLiNS-DYAD-M trial and in this 
cohort the Pearson correlation coefficient between chronological age and microbiota age was 0.71 
(p<0.0001).(8) The sparse RF-generated model is based on the relative abundances of 25 OTUs that 
were most age-discriminatory. Calculated microbiota ages of study participants were compared to the 
median microbiota age of same-aged infants in the reference group to obtain microbiota-for-age Z- 
scores (MAZ-scores). Details on this method have been described previously.(7,8) Microbiota 
diversity has been shown to increase with age during the first years of life and can thus be seen as an 
additional measure of microbiota maturity.(1,2) Shannon’s diversity index was calculated with the 
package phyloseq in R version 3.2.1.(20) To account for unequal library sizes, OTU counts were 
rarefied to 5000 reads before MAZ-scores and Shannon’s diversity index were calculated. To 
investigate associations  between childhood morbidity and  the  relative abundances  of  individual 
bacterial taxa, unrarefied OTU counts that were normalized using cumulative sum-scaling (CSS) were 
included as outcomes in descriptive analyses.(21) Further, outcomes of descriptive analyses included 
unweighted and weighted UniFrac distances between samples as measures of phylogenetic 
dissimilarity.(22,23) 
Morbidity variables consisted of measures of fever, diarrhea, and respiratory symptoms, which 
were assessed at weekly home visits between birth and 18 months. Care-givers were asked to report 
any illness symptoms that the child had in the previous seven days. Diarrhea was defined as three or 
more liquid/semi-liquid stools per day, and respiratory symptoms were defined as difficult breathing, 
cough, or nasal discharge in the absence of diarrhea. In addition, data collectors measured each child’s 
temperature at each home visit, and a temperature of 37.5o C or above was defined as fever. These 
morbidity data, which were available for each day for diarrhea and respiratory symptoms and each 
week for fever, were used to construct several predictor variables to examine the long- and short-term 
influence of morbidity on microbiota. The longitudinal prevalences of diarrhea, respiratory symptoms, 
and fever between 0 and 18 months were used as continuous variables. Longitudinal prevalence was 
defined as the percentage of days with reported diarrhea or respiratory symptoms and as the 
percentage of weeks at which a high temperature was measured for fever.(24) In addition, 
dichotomized variables defined as the presence or absence of any diarrhea, respiratory symptoms, and 
fever, were created for the 30 days preceding fecal sample collection at 6 and 12 months. 
The hypothesis that frequent morbidity is predictive of a subsequent decrease in microbiota 
maturity and diversity was tested using linear regression with MAZ-scores or Shannon’s diversity 
index as a response variable and morbidity variables as predictors. In addition, the models included a 
measure of socioeconomic status (household assets score including information on building materials 
of the house, energy and water source)(25), ownership of domestic animals, water source (piped vs. 
any other), sanitary facility (water closet or ventilation improved pit latrine vs. none or regular pit 
latrine), season of fecal sample collection, maternal characteristics (age, years of education, marital 
status, and HIV status), the exact age of the child at sample collection, child sex, delivery mode, 
library size from 16S rRNA sequencing, and sample processing pool. Breast-feeding, household 
crowding, and antibiotics use as potential confounders had to be excluded from the analysis because 
of too many missing observations at the time points studied (>20%). Before the main analyses, we 
tested for effect modification by the nutrition intervention by adding the intervention group as an 
interaction term to all models. Analyses were carried out in STATA version 13. 
To describe specific differences in gut microbiota composition in relation to morbidity, 
differences in the abundances of bacterial taxa were analyzed at OTU level in STATA. Differences in 
relative abundances of specific OTUs were tested with multivariable zero-inflated negative binominal 
models to adjust for probability of zero count in relation to library size, while all the covariates 
aforementioned were included in the analysis. All OTUs that had non-zero counts in at least 5% of all 
samples were included in the analyses. To analyze whether morbidity predicts overall microbiota 
composition, differences in UniFrac distances were tested with permutational analysis of variance 
(PERMANOVA) using the adonis function in R.(26) The PERMANOVA models included all 
covariates and assessed the marginal effect of morbidity. Pseudo p-values were obtained through 1000 
permutations. 
For analyses on microbiota composition and subsequent morbidity prevalence, microbiota 
variables including MAZ-score, Shannon index, and relative abundances of OTUs at 6 and 12 months 
were used as predictor variables. Outcome variables included the longitudinal prevalence of morbidity 
symptoms at 6 to 12 and 12 to 18 months as continuous variables and any symptoms in the 30 days 
after fecal sample collection at 6 and 12 months as dichotomous variables. To analyze whether MAZ- 
score and Shannon index predict subsequent morbidity, negative binomial regression was used for 
analysis of number of days ill, with an offset for the number of observation days, and logistic 
regression was used for dichotomous outcomes. To analyze whether relative abundances of individual 
OTUs predict subsequent morbidity, abundances of all OTUs that were present in at least 5% of 
samples were transformed to three separate dichotomized variables (zero counts vs. below median 
counts, below median counts vs. above median counts, and zero counts vs. above median counts) and 
analyzed in fully covariate-adjusted negative binominal models. 
All p-values from analyses with relative abundances of individual OTUs as predictor or outcome 
variables were adjusted for multiple hypothesis testing using the Benjamini-Hochberg false discovery 
rate (FDR) correction (q-value). 
The iLiNS-DYAD study was approved by the College of Medicine Research and Ethics 
Committee (COMREC) and the ethics committee of the Pirkanmaa hospital district. All participants 
provided informed consent at enrollment by signing or thumb printing a consent form. The trial was 
registered at clinicaltrials.gov as NCT0123969. 
Results 
There were 790 live-born infants including 8 pairs of twins in the follow-up cohort of the iLiNS- 
DYAD study. By 30 months, a total of 46 participants had not consented to extended follow-up 
beyond 18 months, 78 had died, and 68 were otherwise lost to follow-up. Microbiota data were 
available for 564 participants at 6 months, 632 at 12 months, 631 at 18 months, and 579 at 30 months. 
(see Figure, Supplemental Digital Content 1, http://links.lww.com/MPG/B675). 
On average, children included in the analyses were born at 39.5 weeks gestation with a birth 
length of 49.7 cm and their mothers were 25 years of age at enrollment. Most did not have access to 
piped water or improved sanitary facilities. Compared to participants who did not provide microbiota 
data, the included participants were on average born at a higher gestational age, had higher length-for- 
age Z-score at birth, and their households had a lower mean asset index and less often access to piped 
water (see Table, Supplemental Digital Content 2, http://links.lww.com/MPG/B676). 
The mean (SD) microbiota-for-age Z-score (MAZ) was 0.77 (3.0) at 6 months, -0.24 (2.68) at 12 
months, -1.30 (1.78) at 18 months, and -3.70 (2.55) at 30 months. The mean (SD) Shannon index was 
1.63 (0.67) at 6 months, 2.40 (0.67) at 12 months, 2.95 (0.62) at 18 months, and 3.54 (0.46) at 30 
months. The two outcome measures were strongly correlated with each other at 6 (r=0.66, p<0.001), 
12 (r=0.76, p<0.001), and 18 months (r=0.77, p<0.001) and moderately correlated at 30 months 
(r=0.44, p<0.001). 
The mean (SD) prevalence of morbidity symptoms as percentage of days with symptoms between 
birth and 18 months was 2.2% (3.2%) for diarrhea and 11.5% (10.4%) for respiratory symptoms. A 
temperature above 37.5°C was measured on average at 1.5% (4.1%) of all weekly visits between birth 
and 18 months. 
We found no evidence of effect modification by the nutrition intervention (p>0.1 for all 
interaction terms) and participants from all three intervention groups were analyzed together. Children 
who had any diarrhea at 11 to 12 months had on average a 0.582 (95% CI -1.124;-0.041) lower MAZ- 
score at 12 months than children who did not have diarrhea, and children with respiratory symptoms 
at 11 to 12 months had on average a 0.129 (95% CI 0.018;0.241) higher Shannon Index at 12 months 
than children with no respiratory symptoms (Table 1). No associations between the longitudinal 
prevalence of morbidity symptoms between birth and 18 months and MAZ-score or Shannon Index at 
18 or 30 months were found (see Table, Supplemental Digital Content 3, 
http://links.lww.com/MPG/B677). 
In analyses of differences in microbiota composition at the level of individual taxa, longitudinal 
prevalences of fever, diarrhea, and respiratory symptoms between birth and 18 months were 
predictive of relative abundances of 25 OTUs at 18 and 28 OTUs at 30 months (q<0.05). Any fever, 
diarrhea, and respiratory symptoms in the 30 days preceding sample collection was predictive of 
relative abundances of 64 OTUs at 6 and 95 OTUs at 12 months. All OTUs included in the analyses 
are listed in the Table in Supplemental Digital Content 4 (http://links.lww.com/MPG/B678) and 
visualized as volcano plots in Supplemental Digital Content 5 (http://links.lww.com/MPG/B679). 
Several associations were observed with OTUs that have been previously associated with age or 
growth phenotypes. Among others, diarrhea in the 30 days preceding sample collection was at 6 
months negatively associated with the relative abundances of an OTU assigned to the species 
Bifidobacterium bifidum (q<0.001) and an OTU assigned to the species Bifidobacterium 
pseudolongum (q=0.002) and positively associated with the relative abundance of an OTU assigned to 
the genus Ruminococcus (q=0.04), while respiratory symptoms were positively associated with the 
relative abundance of an OTU assigned to the species Prevotella copri (q=0.01) and fever was 
negatively associated with the relative abundance of an OTU assigned to the genus Faecalibacterium 
(q=0.04). At 12 months, diarrhea preceding sample collection was positively associated with the 
relative abundances of OTUs assigned to the species Clostridium aldenense (q=0.03) and Clostridium 
sordellii (q=0.005). Longitudinal prevalence of fever at 0 to 18 months was negatively associated with 
the relative abundance of an OTU assigned to the genus Prevotella (q=0.04) at 18 months. (Table 2) 
Diarrhea in the 30 days preceding sample collection was associated with both unweighted and 
weighted UniFrac distances at 6 months (p=0.002 and p=0.001) and at12 months (p=0.002 and 
p=0.005). Additionally, respiratory symptoms were associated with unweighted UniFrac distances at 
12 months (p=0.018, p=0.056 for weighted UniFrac distance). (See Table, Supplemental Digital 
Content 6, http://links.lww.com/MPG/B680) 
Significant associations between microbiota composition and subsequent morbidity were also 
observed. Higher MAZ-scores and diversity at 6 months were both predictive of less fever at 6 to 12 
months. For every one-unit increase in MAZ-score at 6 months, the number of days with fever 
between 6 and 12 months decreased by 13% (rate ratio [RR] 0.87, 95% CI 0.78; 0.96), and for every 
one-unit increase in Shannon Index, it decreased by 33% (RR 0.67, 95% CI 0.47; 0.96). All results of 
analyses on microbiota maturity and diversity and subsequent morbidity outcomes are shown in 
Tables 3 and 4. In analyses with relative abundances of individual OTUs as predictors, no OTUs at 6 
or 12 months were found to predict presence of fever, diarrhea, or respiratory symptoms in the 30 
days after sample collection after correcting for multiple hypothesis testing. 
Discussion 
The present study investigated whether morbidity prevalence is predictive of future microbiota 
composition in a low-income setting and tested the hypothesis that frequent morbidity is associated 
with less mature and less diverse microbiota in children in rural Malawi. Secondary analyses 
identified bacterial OTUs whose relative abundances were significantly associated with previous 
morbidity. This study also assessed whether measures of microbiota composition are predictive of 
subsequent morbidity. 
Diarrhea from 11 to 12 months of age was predictive of reduced microbial maturity at 12 months, 
and respiratory symptoms from 11 to 12 months were predictive of increased microbial diversity at 12 
months. At all time-points, morbidity preceding sample collection was predictive of the relative 
abundances of specific bacterial taxa, several of which are part of the model used to construct MAZ- 
scores (i.e., age-discriminatory taxa) or have previously been found to be part of random forests 
derived models predicting lean mass or weight gain in mice (i.e., growth-discriminatory taxa).(8) 
UniFrac distances were associated with diarrhea preceding sample collection at 6 and 12 months and 
with respiratory symptoms preceding sample collection at 12 months. Higher levels of both 
microbiota maturity and diversity at 6 months were found to be predictive of reduced fever incidence 
in the subsequent 6 months. After correcting for multiple hypothesis testing, relative abundances of 
individual OTUs were not predictive of subsequent morbidity. 
Our study had several strengths including a large sample size, an intensive and standardized 
follow-up of study participants, and a longitudinal study design. Morbidity data were collected weekly 
during the first 18 months, which enabled us to study associations between the gut microbiota and 
morbidity both before and after fecal sample collection. The process of fecal sample collection was 
designed to ensure sample quality through short transport times and timely freezing of samples after 
collection. However, data on diarrhea and respiratory illness prevalence were self-reported, and fever 
was the only morbidity variable measured by trained data collectors during weekly home visits. Our 
study was limited by missing data on breast-feeding, household crowding, and antibiotics use. 
Previous studies suggest that there is little variation in infant feeding practices in this area as almost 
all children are breastfed during the first 18 months of life, while exclusive breast-feeding beyond one 
month is very rare, but we cannot exclude potential bias by differences in antibiotic intake.(27) 
Because sequencing of the 16S rRNA V4 region provides low accuracy in taxonomic classification at 
species level, there is some uncertainty in the exact species assigned to the OTUs analyzed.(28) In 
addition, participants who did not provide data for this study had higher socioeconomic status than 
participants from whom data were analyzed, although the differences were small and unlikely to 
affect the validity of the results. Because the time points at which microbiota composition was 
examined in our study were 6 months apart, it is conceivable that short-term changes at particular ages 
in between those time-points were not detected. 
Overall, our findings generally do not support the hypothesis that morbidity prevalence predicts a 
subsequent decrease in gut microbiota maturity or diversity. They do, however, suggest that diarrhea 
and respiratory symptoms from 11 to 12 months of age are predictive of microbiota maturity and 
diversity at 12 months of age and that morbidity prevalence may influence overall microbiota 
composition and relative abundances of several bacterial taxa. These include taxa that have previously 
been shown to be age-discriminatory in this study sample and growth-discriminatory in gnotobiotic 
mice colonized with the fecal microbiota of participants from this study.(8) There was no consistent 
pattern in differences of taxa abundances across the time points and types of symptoms studied. 
Microbiota diversity and maturity may also be associated with the subsequent incidence of fever in 
children in rural Malawi. The observed associations were different for specific morbidity symptoms 
which suggests that the studied symptoms cannot be thought of as one entity in terms of their 
relationship with the gut microbiota. 
It is not clear whether morbidity is a cause or consequence of changes in microbiota composition. 
Moreover, the effect of morbidity on the microbiota could be mediated through increased antibiotics 
use, which has been shown to influence microbiota composition and an individual’s susceptibility to 
infections.(12,29,30) Previous studies suggest that diarrhea leads to at least short-term changes in gut 
microbiota, which is also supported by our findings.(10,31,32) Abundances of several age- 
discriminatory OTUs were associated  with prior diarrhea frequency. It is thus conceivable that 
diarrhea affects age-dependent changes in microbiota composition. Since we did not collect samples 
during acute episodes of diarrhea, these associations are likely not due to changes in stool consistency, 
which has been reported to influence microbiota composition.(33) The finding that respiratory 
symptoms are positively associated with microbiota diversity at 12 months is unexpected. It is 
possible that this is a random finding or a reflection of changes in overall microbiota composition as 
UniFrac distances seem to be associated with preceding respiratory symptoms. In the course of 
normal gut microbiota development, diversity increases rapidly around the age of 12 months. 
Therefore, morbidity could have a stronger influence on overall microbiota maturity and diversity at 
12 months than at other time points. 
Fever as measured weekly by data collectors was predictive of microbiota composition and was 
also predicted by microbiota maturity and diversity. This association has not been reported before; 
however, fever can be seen as a marker of systemic inflammation and interactions between the 
immune system and gut microbiota are well documented.(34) The gut microbiota has also previously 
been linked with malaria, which is a common cause of fever in the study population.(14,35) 
Taken together, our results suggest that in the studied rural Malawian setting, diarrhea from 11 to 
12 months of age is predictive of lower levels of microbiota maturity at 12 months, respiratory 
symptoms from 11 to 12 months of age are predictive of higher levels of microbiota diversity at 12 
months, and higher levels of microbiota maturity and diversity at 6 months may be associated with a 
lower subsequent incidence of fever. Specific morbidity symptoms might be associated with changes 
in the relative abundances of several bacterial taxa and overall microbial community composition. 
There was no clear consistent pattern in the associations between microbiota and morbidity. 
Therefore, we cannot conclude from these findings whether a reduction in disease burden could 
contribute to a healthy microbiota development or whether modifications of the microbiota could 
reduce morbidity. Further studies on the mechanisms of interactions between pathogens, microbiota 
and immunity are needed to assess whether microbiota related interventions could have the potential 
to improve child health outcomes in this population. 
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Table 1. Morbidity at 30 days before sample collection predicting the study participants’ 
microbiota diversity and maturity at 6 and 12 months. Results from covariate adjusted 
multivariable analysis.a 
6 months 
Exposure variables 
MAZ-score Shannon Index 
Coefficient (95%CI) P-value Coefficient (95%CI) P-value 
Fever 5-6 months -0.4 (-1.105;0.304) 0.265 -0.156 (-0.353;0.041) 0.12 
Diarrhea 5-6 months 0.088 (- 0.403;0.579) 0.724 0.095 (-0.043;0.233) 0.178 
Respiratory symptoms 5-6 
months 
-0.02 (-0.384;0.343) 0.91 -0.035 (-0.137;0.068) 0.505 
12 months 
Exposure variables 
MAZ-score Shannon Index 
Coefficient (95%CI) P-value Coefficient (95%CI) P-value 
Fever 11-12 months 0.097 (- 0.859;1.053) 0.842 -0.059 (-0.308;0.189) 0.638 
Diarrhea 11-12 months -0.582 (-1.124;-0.041) 0.035 -0.126 (-0.264;0.013) 0.075 
Respiratory symptoms 11-
12 months 
-0.012 (-0.45;0.426) 0.958 0.129 (0.018;0.241) 0.023 
  MAZ-score, microbiota-for-age Z-score; CI, confidence interval 
a adjusted for Household assets Z-score, ownership of any chicken, goats, and cows, source of drinking  
water, type of sanitary facility, maternal education, age, marital status, and HIV, child sex, delivery   
mode, season of sample collection, exact age at sample collection, sequencing depth, and 
sample processing pool 
Table 2. Time points at which age and growth discriminatory OTUs were associated 
with preceding morbidity 
Outcome Exposure variable Random forests derived model 
OTU ID Taxonomy Fever Diarrhea Respiratory symptoms Age 
Weight 
gain 
Lean 
mass 
gain 
191361 Ruminococcus sp 5 1 39BFAA 6 months X 
199145 Faecalibacterium sp DJF VR20 6 months X 
365385 Bifidobacterium bifidum 6 months X 
681370 Bifidobacterium pseudolongum 6 months X X X 
4436552 Prevotella copri 6 months X 
2148365 Clostridium aldenense 12 months X 
242298 Clostridium sordellii 12 months X 
4318208 Prevotella 18 months X 
The time point at which the OTU is associated with preceding morbidity is marked in green for 
positive and red for negative associations. The last columns indicate whether the OTU was 
previously found to be part of a random forests derived model predicting age in Malawian children 
or weight gain or lean mass gain in mice.(8) 
Table 3. The study participants’ microbiota diversity and maturity at 6 and 12 months 
predicting the number of days ill in the subsequent 6-month period. Results from negative 
binomial covariate adjusted multivariable analysis.a 
6-12 months 
Exposure variables 
 Fever     Diarrhea Respiratory symptoms 
RR (95%CI) P-value RR (95%CI) P-value RR (95%CI) P-value 
MAZ-score at 6 
months 
0.87 (0.78;0.96) 0.007 0.99 (0.91;1.08) 0.837 0.97 (0.92;1.03) 0.323 
Shannon Index at 6 
months 
0.67 (0.47;0.96) 0.031 0.98 (0.72;1.34) 0.914 0.97 (0.78;1.19) 0.759 
12-18 months 
Exposure variables 
 Fever  Diarrhea Respiratory symptoms 
RR (95%CI) P-value RR (95%CI) P-value RR (95%CI) P-value 
MAZ-score at 12 
months 
0.96 (0.90;1.03) 0.259 1.02 (0.96;1.09) 0.427 1.03 (0.98;1.07) 0.243 
Shannon Index at 12 
months 
0.9 (0.7;1.16) 0.428 1.16 (0.9;1.5) 0.261 1.14 (0.97;1.34) 0.117 
MAZ-score, microbiota-for-age Z-score; RR, rate ratio; CI, confidence interval 
a adjusted for Household assets Z-score, ownership of any chicken, goats, and cows, source of 
drinking water, type of sanitary facility, maternal education, age, marital status, and HIV, child sex, 
delivery mode, season of sample collection, exact age at sample collection, sequencing depth, and 
sample processing pool 
Table 4. The study participants’ microbiota diversity and maturity at 6 and 12 months 
predicting morbidity in the subsequent 30 days. Results from covariate adjusted multivariable 
logistic regression.a 
6-7 months 
Exposure variables 
 Fever  Diarrhea Respiratory symptoms 
Odds ratio 
(95%CI) 
P-value Odds ratio 
(95%CI) 
P-value Odds ratio (95%CI) P-value 
MAZ-score at 6 
months 
0.95 
(0.73;1.24) 
0.731 1.01 
(0.87;1.16) 
0.921 1.01 (0.91;1.12) 0.880 
Shannon Index at 6 
months 
0.66 
(0.24;1.82) 
0.419 1.20 
(0.74;1.97) 
0.461 0.77 (0.53;1.12) 0.170 
12-13 months 
Exposure variables 
 Fever  Diarrhea Respiratory symptoms 
Odds ratio 
(95%CI) 
P-value Odds ratio 
(95%CI) 
P-value Odds ratio (95%CI) P-value 
MAZ-score at 12 
months 
0.80 (0.63;1.00) 0.054 1.06 
(0.96;1.16) 
0.259 0.98 (0.91;1.06) 0.631 
Shannon Index at 12 
months 
0.47 (0.22;1.01) 0.053 1.38 
(0.94;2.03) 
0.096 1.10 (0.83;1.46) 0.509 
MAZ-score, microbiota-for-age Z-score; CI, confidence interval 
a adjusted for Household assets Z-score, ownership of any chicken, goats, and cows, source of 
drinking water, type of sanitary facility, maternal education, age, marital status, and HIV, child sex, 
delivery mode, season of sample collection, exact age at sample collection, sequencing depth, and 
sample processing pool 
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46 did not consent to add-on visits 
7 deaths 
22 drop-outs 
19 samples missed at 30 months 
51 no morbidity data available 
9310 pregnant women approached 
522 simplified follow-up 
782 women giving birth to 790 children (including 8 sets of 
twins) 
869 women in complete follow-up (10 twins) 
Stool sample available from 631 at 18 months, all data 
available for 575 
1391 pregnant women enrolled 
22 abortion or stillbirth 
65 drop-outs 
71 deaths 
46 drop-outs 
42 samples missed at 18 months 
56 no morbidity data available 
Stool sample available from 579 at 30 months, all data 
available for 528 
7919 Exclusions 
3470 not interested 
2760 out of area 
1333 >20 gestation weeks or duration of 
pregnancy unknown 
310 not available 
9 underage 
1 earlier participation 
30 medical condition 
6 other 
8 sets of twins 
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Supplemental Digital Content 2. Characteristics of included and excluded study 
participants 
Characteristic Included Excluded P-value 
Participants, n 651 228 
Maternal age at enrollment, 
years  25 (20;29) 23 (19;28) 0.009 
Maternal education 
completed, years 3 (0;6) 4 (2;8) 0.006 
Positive malaria RDT of the 
mother at enrollment 23% 23% 0.837 
Positive HIV status of the 
mother 12% 12% 0.9 
Gestational age at birth, 
weeks 39.7 (38.7;40.6) 39.3 (37;40) 0.0003 
Child born by cesarean 
section 6% 5% 0.62 
Child sex (female) 52% 54% 0.723 
LAZ at birth -1.0 (1.1) -1.6 (1.3) <0.001 
Length at birth 49.7 (2.2) 48.9 (2.4) 0.002 
LAZ at 18 months -1.6 (1.1) -2.1 (1.5) 0.027 
Length at 18 months 77.0 (3.0) 75.8 (4.5) 0.024 
Household assets Z-score -0.1 (0.9) 0.4 (1.2) <0.001 
Ownership of any chicken 55% 46% 0.053 
Ownership of any goats 29% 24% 0.292 
Ownership of any cows 5% 2% 0.237 
Source of drinking water is 
borehole, well, river or lake 
(instead of piped) 
86% 69% <0.001 
Type of sanitary facility is 
none or regular pit latrine 
(instead of ventilation 
improved pit latrine or water 
closet) 
90% 89% 0.717 
Values are in mean or median (standard deviation or interquartile range) or percentages.  
P-values are obtained from Mann-Whitney test or t-test (continuous variables) or chi-square 
test (proportions). 
LAZ, length-for-age Z score; RDT, rapid diagnostic test 
Supplemental Digital Content JPGN-19-306R2_SDC2.docx
Supplemental Digital Content 3. Morbidity prevalence at 0-18 months predicting the 
study participants’ microbiota diversity and maturity at 18 and 30 months. Results from 
covariate adjusted multivariable analysis.a
MAZ-score, microbiota-for-age Z-score 
a adjusted for Household assets Z-score, ownership of any chicken, goats, and cows, source of 
drinking water, type of sanitary facility, maternal education, age, marital status, and HIV, 
child sex, delivery mode, season of sample collection, exact age at sample collection, 
sequencing depth, and sample processing pool 
18 months 
Exposure variables 
MAZ-score Shannon Index 
Coefficient 
(95%CI) P-value 
Coefficient 
(95%CI) P-value 
Prevalence of fever 0-18 months -0.025 (-0.11;0.06) 0.565 
0.016  
(-0.013;0.045) 0.284 
Prevalence of diarrhea 0-18 
months 
-0.01  
(-0.061;0.041) 0.703 
0.002  
(-0.015;0.02) 0.810 
Prevalence of respiratory 
symptoms 0-18 months 
-0.003  
(-0.02;0.015) 0.771 
0.002  
(-0.004;0.007) 0.589 
30 months 
Exposure variables 
MAZ-score Shannon Index 
Coefficient 
(95%CI) P-value 
Coefficient 
(95%CI) P-value 
Prevalence of fever 0-18 months -0.044  (-0.172;0.084) 0.503 
0.0005  
(-0.022;0.023) 0.964 
Prevalence of diarrhea 0-18 
months 
-0.052  
(-0.128;0.025) 0.184 
0.011  
(-0.002;0.025) 0.097 
Prevalence of respiratory 
symptoms 0-18 months 
0.004  
(-0.02;0.029) 0.753 
0.0002  
(-0.004;0.005) 0.924 
Supplemental Digital Content JPGN-19-306R2_SDC3.docx
Differences in relative abundances of OTUs at 6 and 12 months predicted by any diarrhea, respiratory symptoms or fever in the 30 days preceding sample collection and differences in relative abundances of 
OTUs at 18 and 30 months predicted by longitudinal prevalence of diarrhea, respiratory symptoms or fever at 0 to 18 months. Ln fold-change plotted against respective q-values (fdr-corrected p-values), dots 
represent OTUs and are colored by phylum. Plots of 18 and 30 months data are scaled differently from 6 and 12 months data for better visualization.
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Supplemental Digital Content 6. Morbidity predicting differences in UniFrac distances 
6 months 
Exposure variables 
unweighted UniFrac distance weighted UniFrac distance 
R2-value pseudo P-value R2-value pseudo P-value 
Fever 5-6 months 0.002 0.625 0.002 0.392 
Diarrhea 5-6 months 0.006 0.002 0.015 0.001 
Respiratory symptoms 5-6 months 0.003 0.177 0.001 0.751 
12 months 
Exposure variables 
unweighted UniFrac distance weighted UniFrac distance 
R2-value pseudo P-value R2-value pseudo P-value 
Fever 11-12 months 0.002 0.731 0.001 0.737 
Diarrhea 11-12 months 0.006 0.002 0.008 0.005 
Respiratory symptoms 11-12 
months 
0.004 0.018 0.004 0.056 
18 months 
Exposure variables 
unweighted UniFrac distance weighted UniFrac distance 
R2-value pseudo P-value R2-value pseudo P-value 
Fever 0-18 months 0.002 0.527 0.003 0.121 
Diarrhea 0-18 months 0.001 0.714 0.001 0.834 
Respiratory symptoms 0-18 
months 
0.001 0.708 0.001 0.929 
30 months 
Exposure variables 
unweighted UniFrac distance weighted UniFrac distance 
R2-value pseudo P-value R2-value pseudo P-value 
Fever 0-18 months 0.002 0.427 0.001 0.717 
Diarrhea 0-18 months 0.002 0.151 0.001 0.953 
Respiratory symptoms 0-18 
months 
0.002 0.474 0.001 0.879 
Results from permutational analysis of variance models assessing the marginal effect of morbidity and including 
household assets Z-score, ownership of any chicken, goats, and cows, source of drinking water, type of sanitary facility, 
maternal education, age, marital status, and HIV, child sex, delivery mode, season of sample collection, exact age at 
sample collection, sequencing depth, and sample processing pool as covariates. Pseudo p-values were obtained through 
1000 permutations. 
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